|
1
|
Wu X, Wan M, Li G, Xu Z, et al: Growth
hormone receptor overexpression predicts response of rectal cancers
to pre-operative radiotherapy. Eur J Cancer. 42:888–894. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Madrid O, Varea S, Sanchez-Perez I, et al:
Growth hormone protects against radiotherapy-induced cell death.
Eur J Endocrinol. 147:535–541. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Isla A, Budke M, García-Grande A, et al:
Protective effects of the growth hormone (GH) on the irradiated
spinal cord in rats. Neurocirugia (Astur). 18:89–94. 2007.(In
Spanish).
|
|
4
|
Isla A, Budke M, Cacicedo L, et al:
Protective effects of growth hormone in cell cultures of the
central nervous system. Rev Neurol. 34:208–211. 2002.(In
Spanish).
|
|
5
|
Bougen NM, Steiner M, Pertziger M, et al:
Autocrine human GH promotes radioresistance in mammary and
endometrial carcinoma cells. Endocr Relat Cancer. 19:625–644. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dunne AL, Price ME, Mothersill C, et al:
Relationship between clonogenic radiosensitivity, radiation-induced
apoptosis and DNA damage/repair in human colon cancer cells. Br J
Cancer. 89:2277–2283. 2003. View Article : Google Scholar
|
|
7
|
Rojas E, Lopez MC and Valverde M: Single
cell gel electrophoresis assay: methodology and applications. J
Chromatogr B Biomed Sci Appl. 722:225–254. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Collins AR: The comet assay for DNA damage
and repair: principles, applications, and limitations. Mol
Biotechnol. 26:249–261. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lee E, Oh E and Lee J, Sul D and Lee J:
Use of the tail moment of the lymphocytes to evaluate DNA damage in
human biomonitoring studies. Toxicol Sci. 81:121–132. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fuh G, Cunningham BC, Fukunaga R, et al:
Rational design of potent antagonists to the human growth hormone
receptor. Science. 256:1677–1680. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Willers H, Dahm-Daphi J and Powell SN:
Repair of radiation damage to DNA. Br J Cancer. 90:1297–1301. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Thompson BJ, Shang CA and Waters MJ:
Identification of genes induced by growth hormone in rat liver
using cDNA arrays. Endocrinology. 141:4321–4324. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang XW, Zhan Q, Coursen JD, et al: GADD45
induction of a G2/M cell cycle checkpoint. Proc Natl Acad Sci USA.
96:3706–3711. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liebermann DA and Hoffman B: Gadd45 in
stress signaling. J Mol Signal. 3:152008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fishel ML and Kelley MR: The DNA base
excision repair protein Ape1/Ref-1 as a therapeutic and
chemopreventive target. Mol Aspects Med. 28:375–395. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Argetsinger LS and Carter-Su C: Growth
hormone signalling mechanisms: involvement of the tyrosine kinase
JAK2. Horm Res. 45(Suppl 1): 22–24. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Love DW, Whatmore AJ, Clayton PE and Silva
CM: Growth hormone stimulation of the mitogen-activated protein
kinase pathway is cell type specific. Endocrinology. 139:1965–1971.
1998.PubMed/NCBI
|
|
18
|
Möller C, Hansson A, Enberg B, et al:
Growth hormone (GH) induction of tyrosine phosphorylation and
activation of mitogen-activated protein kinases in cells
transfected with rat GH receptor cDNA. J Biol Chem.
267:23403–23408. 1992.PubMed/NCBI
|
|
19
|
Argetsinger LS, Hsu GW, Myers MG Jr, et
al: Growth hormone, interferon-gamma, and leukemia inhibitory
factor promoted tyrosyl phosphorylation of insulin receptor
substrate-1. J Biol Chem. 270:14685–14692. 1995. View Article : Google Scholar
|
|
20
|
Argetsinger LS, Norstedt G, Billestrup N,
et al: Growth hormone, interferon-gamma, and leukemia inhibitory
factor utilize insulin receptor substrate-2 in intracellular
signalling. J Biol Chem. 271:29415–29421. 1996. View Article : Google Scholar
|
|
21
|
Jeay S, Sonenshein GE, Kelly PA, et al:
Growth hormone exerts antiapoptotic and proliferative effects
through two different pathways involving nuclear factor-kappaB and
phosphatidylinositol 3-kinase. Endocrinology. 142:147–156.
2001.
|
|
22
|
VanderKuur J, Allevato G, Billestrup N, et
al: Growth hormone-promoted tyrosyl phosphorylation of SHC proteins
and SHC association with Grb2. J Biol Chem. 270:7587–7593. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Argetsinger LS and Carter-Su C: Mechanism
of signalling by growth hormone receptor. Physiol Rev.
76:1089–1107. 1996.PubMed/NCBI
|
|
24
|
Wang YD and Wood WI: Amino acids of the
human growth hormone receptor that are required for proliferation
and Jak-STAT signalling. Mol Endocrinol. 9:303–311. 1995.PubMed/NCBI
|
|
25
|
Pircher TJ, Flores-Morales A, Mui AL, et
al: Mitogen-activated protein kinase inhibition decreases growth
hormone stimulated transcription mediated by STAT5. Mol Cell
Endocrinol. 133:169–176. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ihle JN, Witthuhn BA, Quelle FW, et al:
Signalling through the hematopoietic cytokine receptors. Ann Rev
Immunol. 13:369–398. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Drake WM and Trainer PJ: Clinical use of
pegvisomant for the treatment of acromegaly. Treat Endocrinol.
2:369–374. 2003. View Article : Google Scholar : PubMed/NCBI
|
